We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The company says it marks he first FDA-approved trial intended to show that pulmonary embolism can be treated by removing the clot through a percutaneous procedure. Read More
The UK’s healthcare costs regulator is recommending Terumo BCT’s Spectra Optia Apheresis System for blood transfusion in managing sickle cell disease, saying the device may lead to fewer treatments that last for shorter periods of time. Read More